activins and Adenocarcinoma

activins has been researched along with Adenocarcinoma in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (22.73)18.2507
2000's7 (31.82)29.6817
2010's6 (27.27)24.3611
2020's4 (18.18)2.80

Authors

AuthorsStudies
Koniaris, LG; Liu, S; Liu, Y; Narasimhan, A; Shahda, S; Silverman, LM; Wan, J; Young, AR; Zhong, X; Zimmers, TA1
Arnold, A; Berg, E; Daum, S; Hummel, M; Kühl, AA; Pötzsch, M; Rau, B; Staudacher, JJ; Stein, U; Treese, C; Winterfeld, M1
Borkowska, A; Malecka-Panas, E; Olakowski, M; Talar-Wojnarowska, R; Wozniak, M1
Bauer, J; Castellanos, K; Dawson, D; Grimaldo, S; Grippo, P; Guzman, G; Hwang, R; Jung, B; Krett, N; Mancinelli, G; McKinney, R; Torres, C1
Li, S; Shan, Y1
Andl, CD; Andl, T; El-Rifai, W; Koumangoye, RB; Le Bras, GF; Loomans, HA; Quast, LL; Romero-Morales, AI; Taylor, C; Zaika, AI1
Cui, XL; Liu, ZH; Niu, LM; Qi, Y; Wu, S; Xie, DX1
Bendek, M; Berger, W; Berta, J; Dome, B; Grusch, M; Hegedus, B; Hoda, MA; Klepetko, W; Klikovits, T; Lang, E; Laszlo, V; Lohinai, Z; Renyi-Vamos, F; Rozsas, A; Torok, S1
Ahmad, J; El-Shemi, AG; Idris, S; Kensara, OA; Mohamed, AM; Refaat, B1
Beer, DG; Chang, AC; Chen, G; Giordano, TJ; Hartojo, W; Lin, L; Orringer, MB; Seder, CW; Silvers, AL; Thomas, DG; Wang, Z1
Bao, YL; Huang, YX; Li, YX; Shi, Y; Sun, Y; Wu, Y; Yu, CL; Zheng, LH1
Minami, S; Otani, T; Tanaka, T; Toujima, S; Umesaki, N; Yamoto, M1
Tanaka, T; Toujima, S; Umesaki, N1
Kimura, F; Noda, Y; Takahashi, K; Takebayashi, K1
Burger, HG; Gurusinghe, CJ; Healy, DL; Jobling, T; Mamers, P1
Ying, SY; Zhang, Z1
Huang, G; Li, SQ; Ying, C; Ying, SY; Zhang, Z1
Di Blasio, AM; Florio, P; Gadducci, A; Gallo, R; Genazzani, AR; Luisi, S; Petraglia, F; Vale, W; Viganò, P1
Fukuda, J; Ito, I; Leung, PC; Tanaka, T1
Auersperg, N; Fukuda, J; Ito, I; Leung, PC; Minegishi, T; Shinozaki, H1
Minami, S; Otani, T; Umesaki, N; Yamoto, M1
Caliandro, D; Caruso, A; Castellani, R; Di Simone, N; Schneyer, AL1

Reviews

1 review(s) available for activins and Adenocarcinoma

ArticleYear
[Activins and uterine endometrium].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 4

    Topics: Activin Receptors; Activins; Adenocarcinoma; Embryo Implantation; Endometrial Neoplasms; Endometrium; Female; Humans; Inhibin-beta Subunits; Pregnancy

2006

Other Studies

21 other study(ies) available for activins and Adenocarcinoma

ArticleYear
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Journal of cachexia, sarcopenia and muscle, 2022, Volume: 13, Issue:4

    Topics: Activins; Adenocarcinoma; Animals; Cachexia; Carcinoma, Pancreatic Ductal; Estradiol; Female; Follistatin-Related Proteins; Humans; Male; Mice; Muscle, Skeletal; Muscular Atrophy; Pancreatic Neoplasms; Phenotype; Sex Factors

2022
Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas.
    BMC cancer, 2022, Sep-05, Volume: 22, Issue:1

    Topics: Activins; Adenocarcinoma; Cytokines; Esophageal Neoplasms; Humans; Inhibin-beta Subunits; Inhibins; Prognosis; Retrospective Studies; Stomach

2022
Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2020, Volume: 71, Issue:1

    Topics: Activins; Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Humans; Male; Middle Aged; Myostatin; Pancreatic Neoplasms; Prospective Studies; Weight Loss

2020
Role of stromal activin A in human pancreatic cancer and metastasis in mice.
    Scientific reports, 2021, 04-12, Volume: 11, Issue:1

    Topics: Activins; Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Epithelial Cells; Epithelium; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Metastasis; Pancreatic Neoplasms; Pancreatic Stellate Cells; Prognosis; Stromal Cells; Survival Analysis; Tumor Burden; Up-Regulation

2021
Expression of Cripto-1 gene protein and Activin-A in human lung adenocarcinoma tissue.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:2 Suppl

    Topics: Activins; Adenocarcinoma; Adenocarcinoma of Lung; Biomarkers, Tumor; Female; GPI-Linked Proteins; Humans; Immunohistochemistry; Inhibin-beta Subunits; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Predictive Value of Tests

2015
Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.
    Oncotarget, 2015, Oct-27, Volume: 6, Issue:33

    Topics: Activins; Adenocarcinoma; Barrett Esophagus; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Fluorescent Antibody Technique; Humans; Neoplasm Invasiveness

2015
Activin A as a novel biomarker for colorectal adenocarcinoma in humans.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:22

    Topics: Activins; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Young Adult

2015
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.
    Oncotarget, 2016, Mar-22, Volume: 7, Issue:12

    Topics: Activins; Adenocarcinoma; Adenocarcinoma of Lung; Biomarkers, Tumor; Case-Control Studies; Cell Proliferation; Female; Follistatin; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Survival Rate; Tumor Cells, Cultured

2016
Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer.
    BMC cancer, 2016, 11-11, Volume: 16, Issue:1

    Topics: Activins; Adenocarcinoma; Animals; Azoxymethane; Biomarkers, Tumor; Carcinogenesis; Colonic Neoplasms; Disease Progression; Follistatin; Gene Expression; Male; Precancerous Conditions; Rats, Wistar

2016
INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:4

    Topics: Activins; Adenocarcinoma; Animals; Cattle; Cell Line, Tumor; Cell Proliferation; Epigenesis, Genetic; Esophageal Neoplasms; Follistatin; Histone Acetyltransferases; Humans; Immunohistochemistry; Inhibin-beta Subunits; RNA, Messenger; RNA, Small Interfering

2009
Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway.
    Journal of biomolecular screening, 2011, Volume: 16, Issue:5

    Topics: Activin Receptors, Type II; Activins; Adenocarcinoma; Cell Line; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; HEK293 Cells; Humans; Intercellular Signaling Peptides and Proteins; Lactones; Neoplasm Proteins; Protein Binding; Sesquiterpenes, Eudesmane; Signal Transduction; Small Molecule Libraries

2011
Expression and function of activin receptors in human endometrial adenocarcinoma cells.
    International journal of oncology, 2003, Volume: 23, Issue:3

    Topics: Activin Receptors; Activins; Adenocarcinoma; Apoptosis; Cell Division; Cell Line, Tumor; Cell Membrane; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endometrium; fas Receptor; Female; Flow Cytometry; Humans; Inhibin-beta Subunits; RNA, Messenger

2003
Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
    Oncology reports, 2004, Volume: 11, Issue:4

    Topics: Activins; Adenocarcinoma; Cell Differentiation; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Female; Flow Cytometry; Humans; Inhibin-beta Subunits; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1

2004
Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
    Gynecologic oncology, 1995, Volume: 57, Issue:1

    Topics: Activins; Adenocarcinoma; Aged; Female; Granulosa Cell Tumor; Growth Substances; Humans; Immune Sera; Immunohistochemistry; Inhibins; Middle Aged; Ovarian Neoplasms

1995
Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.
    Breast cancer research and treatment, 1996, Volume: 37, Issue:2

    Topics: Activin Receptors; Activins; Adenocarcinoma; Base Sequence; Breast Neoplasms; Female; Humans; Immunohistochemistry; In Situ Hybridization; Inhibins; Molecular Sequence Data; Polymerase Chain Reaction; Receptors, Growth Factor; RNA, Messenger; Tumor Cells, Cultured

1996
Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line.
    Journal of endocrinological investigation, 1996, Volume: 19, Issue:1

    Topics: Activin Receptors; Activins; Adenocarcinoma; Animals; Base Sequence; DNA, Complementary; Electrophoresis, Agar Gel; Immunohistochemistry; In Situ Hybridization; Inhibins; Molecular Sequence Data; Pituitary Neoplasms; Polymerase Chain Reaction; Rats; Receptors, Growth Factor; Tumor Cells, Cultured

1996
Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:4

    Topics: Activin Receptors; Activins; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Case-Control Studies; Endometrial Neoplasms; Female; Growth Substances; Humans; Inhibins; Middle Aged; Peptide Fragments; Receptors, Growth Factor; Reference Values; RNA, Messenger; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Uterus

1998
Cell survival effect of activin against heat shock stress on OVCAR3.
    Life sciences, 1998, Volume: 63, Issue:25

    Topics: Activin Receptors; Activins; Adenocarcinoma; Blotting, Western; Cell Division; Cell Survival; Female; Follistatin; Glycoproteins; Growth Substances; Heat-Shock Response; Humans; Inhibins; Ovarian Neoplasms; Receptors, Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Physiological; Tumor Cells, Cultured

1998
Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma.
    British journal of cancer, 2000, Volume: 82, Issue:8

    Topics: Activin Receptors; Activins; Adenocarcinoma; DNA-Binding Proteins; Epithelial Cells; Female; Granulosa Cells; Growth Substances; Humans; Inhibins; Ovarian Neoplasms; Ovary; Receptors, Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad2 Protein; Smad4 Protein; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured

2000
Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
    Gynecologic oncology, 2001, Volume: 83, Issue:1

    Topics: Activins; Adenocarcinoma; Adult; Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Inhibins; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2001
Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol.
    Molecular and cellular endocrinology, 2002, Jun-28, Volume: 192, Issue:1-2

    Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; Adenocarcinoma; Apoptosis; bcl-2-Associated X Protein; Cell Differentiation; Cell Division; Down-Regulation; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibin-beta Subunits; Neoplasm Proteins; Protein Subunits; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured

2002